CN114088675A - Immunoliposome wrapping fluorescent dye and application - Google Patents
Immunoliposome wrapping fluorescent dye and application Download PDFInfo
- Publication number
- CN114088675A CN114088675A CN202111361157.3A CN202111361157A CN114088675A CN 114088675 A CN114088675 A CN 114088675A CN 202111361157 A CN202111361157 A CN 202111361157A CN 114088675 A CN114088675 A CN 114088675A
- Authority
- CN
- China
- Prior art keywords
- solution
- immunoliposome
- fluorescent dye
- liposome
- patulin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007850 fluorescent dye Substances 0.000 title claims abstract description 21
- ZRWPUFFVAOMMNM-UHFFFAOYSA-N Patulin Chemical compound OC1OCC=C2OC(=O)C=C12 ZRWPUFFVAOMMNM-UHFFFAOYSA-N 0.000 claims abstract description 102
- 239000000243 solution Substances 0.000 claims abstract description 47
- 239000002502 liposome Substances 0.000 claims abstract description 40
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 24
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 20
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract description 10
- MKNJJMHQBYVHRS-UHFFFAOYSA-M sodium;1-[11-(2,5-dioxopyrrol-1-yl)undecanoyloxy]-2,5-dioxopyrrolidine-3-sulfonate Chemical compound [Na+].O=C1C(S(=O)(=O)[O-])CC(=O)N1OC(=O)CCCCCCCCCCN1C(=O)C=CC1=O MKNJJMHQBYVHRS-UHFFFAOYSA-M 0.000 claims abstract description 8
- QFMZQPDHXULLKC-UHFFFAOYSA-N 1,2-bis(diphenylphosphino)ethane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)CCP(C=1C=CC=CC=1)C1=CC=CC=C1 QFMZQPDHXULLKC-UHFFFAOYSA-N 0.000 claims abstract description 5
- KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 claims abstract description 5
- 235000012000 cholesterol Nutrition 0.000 claims abstract description 5
- BIABMEZBCHDPBV-UHFFFAOYSA-N dipalmitoyl phosphatidylglycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCCCCCCCCCC BIABMEZBCHDPBV-UHFFFAOYSA-N 0.000 claims abstract description 5
- 238000009210 therapy by ultrasound Methods 0.000 claims abstract description 5
- 239000011259 mixed solution Substances 0.000 claims abstract description 4
- 238000001917 fluorescence detection Methods 0.000 claims description 19
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 17
- 239000007995 HEPES buffer Substances 0.000 claims description 17
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 14
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 12
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 9
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims description 7
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 claims description 6
- HDFGOPSGAURCEO-UHFFFAOYSA-N N-ethylmaleimide Chemical compound CCN1C(=O)C=CC1=O HDFGOPSGAURCEO-UHFFFAOYSA-N 0.000 claims description 6
- 238000000502 dialysis Methods 0.000 claims description 6
- 125000005439 maleimidyl group Chemical group C1(C=CC(N1*)=O)=O 0.000 claims description 6
- 239000011780 sodium chloride Substances 0.000 claims description 6
- 125000003396 thiol group Chemical class [H]S* 0.000 claims description 5
- 230000005284 excitation Effects 0.000 claims description 4
- 239000002105 nanoparticle Substances 0.000 claims description 4
- 239000011550 stock solution Substances 0.000 claims description 4
- QPLPMPAMOJIAMN-UHFFFAOYSA-N 3-oxobutanethioic s-acid Chemical group CC(=O)CC(O)=S QPLPMPAMOJIAMN-UHFFFAOYSA-N 0.000 claims description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 3
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 3
- 229920002684 Sepharose Polymers 0.000 claims description 3
- 239000007853 buffer solution Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 238000011534 incubation Methods 0.000 claims description 3
- 239000012046 mixed solvent Substances 0.000 claims description 3
- 239000008363 phosphate buffer Substances 0.000 claims description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 238000010791 quenching Methods 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims 2
- 238000007865 diluting Methods 0.000 claims 1
- 239000008055 phosphate buffer solution Substances 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract description 11
- 238000002360 preparation method Methods 0.000 abstract description 4
- 230000035945 sensitivity Effects 0.000 abstract description 2
- 239000003053 toxin Substances 0.000 abstract description 2
- 231100000765 toxin Toxicity 0.000 abstract description 2
- 238000000034 method Methods 0.000 description 22
- 239000000725 suspension Substances 0.000 description 11
- 238000004128 high performance liquid chromatography Methods 0.000 description 9
- 235000015197 apple juice Nutrition 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 239000000565 sealant Substances 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- VYLQGYLYRQKMFU-UHFFFAOYSA-N Ochratoxin A Natural products CC1Cc2c(Cl)cc(CNC(Cc3ccccc3)C(=O)O)cc2C(=O)O1 VYLQGYLYRQKMFU-UHFFFAOYSA-N 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- RWQKHEORZBHNRI-BMIGLBTASA-N ochratoxin A Chemical compound C([C@H](NC(=O)C1=CC(Cl)=C2C[C@H](OC(=O)C2=C1O)C)C(O)=O)C1=CC=CC=C1 RWQKHEORZBHNRI-BMIGLBTASA-N 0.000 description 4
- DAEYIVCTQUFNTM-UHFFFAOYSA-N ochratoxin B Natural products OC1=C2C(=O)OC(C)CC2=CC=C1C(=O)NC(C(O)=O)CC1=CC=CC=C1 DAEYIVCTQUFNTM-UHFFFAOYSA-N 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 238000010926 purge Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 230000009260 cross reactivity Effects 0.000 description 3
- 238000002795 fluorescence method Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 238000000527 sonication Methods 0.000 description 3
- 241000228212 Aspergillus Species 0.000 description 2
- 241000228143 Penicillium Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229930183344 ochratoxin Natural products 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000003260 vortexing Methods 0.000 description 2
- 241000228193 Aspergillus clavatus Species 0.000 description 1
- 241000228243 Aspergillus giganteus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000228337 Byssochlamys Species 0.000 description 1
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000226677 Myceliophthora Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241001149514 Penicillium clavigerum Species 0.000 description 1
- 241001148539 Penicillium concentricum Species 0.000 description 1
- 241001150396 Penicillium coprobium Species 0.000 description 1
- 241001123663 Penicillium expansum Species 0.000 description 1
- 241001507686 Penicillium gladioli Species 0.000 description 1
- 241001501993 Penicillium glandicola Species 0.000 description 1
- 241000228127 Penicillium griseofulvum Species 0.000 description 1
- 241001148511 Penicillium marinum Species 0.000 description 1
- 241000960405 Penicillium paneum Species 0.000 description 1
- 241001149509 Penicillium vulpinum Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 206010043275 Teratogenicity Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 231100000260 carcinogenicity Toxicity 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000003271 compound fluorescence assay Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000002038 ethyl acetate fraction Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000007688 immunotoxicity Effects 0.000 description 1
- 231100000386 immunotoxicity Toxicity 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 231100000299 mutagenicity Toxicity 0.000 description 1
- 230000007886 mutagenicity Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 231100000456 subacute toxicity Toxicity 0.000 description 1
- 231100000211 teratogenicity Toxicity 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N21/643—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" non-biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6432—Quenching
Abstract
The invention discloses an immunoliposome wrapping fluorescent dye and application thereof, wherein the preparation method of the immunoliposome comprises the following steps: 1) dissolving DPPE and SATA in a chloroform solution, and carrying out ultrasonic treatment to form DPPE-SATA; dissolving DPPE-SATA, DPPC, DPPG and cholesterol in a mixed solution of chloroform and methanol, and carrying out ultrasonic treatment to form liposome; the liposome is encapsulated by the fluorescent dye to obtain the fluorescent dye encapsulated liposome; 2) modifying the liposome encapsulated by the fluorescent dye by using the antibody derived from the sulfo-KMUS to obtain the immune liposome encapsulating the fluorescent dye. The invention also discloses application of the immunoliposome coated with the fluorescent dye in fluorescent detection of patulin. The detection method using liposome wrapped in SRB as the identification and signal unit shows high sensitivity and specificity, and can be used for rapid detection of the clavulanic toxin.
Description
Technical Field
The invention belongs to the technical field of biology, and particularly relates to an immunoliposome wrapped with a fluorescent dye and an application thereof, in particular to a fluorescence detection technology for patulin in liquid food.
Background
Patulin is a toxic secondary metabolite of some fungal species such as Aspergillus (Aspergillus), Penicillium (Penicillium), Byssochlamys (myceliophthora) and the like. Strains that metabolically produce patulin include a.clavatus, a.giganteus, a.longivisica, p.clavigerum, p.carreum, p.coprobium, p.concentricum, p.dipodomycola, p.glandicola, p.gladioli, p.griseofulvum, p.expansum, p.marinum, p.sclerotigum, p.paneum, and p.vulpinum.
Patulin can contaminate a variety of food products, such as fruits, vegetables, grains, cheese, etc., which can pose a variety of health risks to humans and animals if passed into the body. Several toxicological studies have shown that patulin can invade the skin, kidneys, liver, gastrointestinal tract and nervous system, causing damage to tissues and organs of the human body. In some zoological studies, patulin also has acute and subacute toxicity, immunotoxicity, teratogenicity, mutagenicity, carcinogenicity, and the like.
Currently, the detection method of patulin is mainly a chromatography method, such as thin layer chromatography, high performance liquid chromatography and gas chromatography. Although the chromatography has high sensitivity and high specificity for detecting the clavulanin, the chromatography needs complicated purification steps, a large amount of raw materials and expensive instruments, is not suitable for field real-time detection in actual occasions and does not meet the requirements of the food industry.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and develop a rapid and sensitive detection method for patulin. The invention provides an patulin fluorescence detection method based on immunoliposomes, which is used for developing patulin immunoliposomes by using rabbit anti-patulin BSA antibodies and is applied to the detection of patulin.
The technical scheme of the invention is summarized as follows:
A. preparing a fluorescent dye encapsulated liposome;
B. preparing an anti-aspergillus clavatus-BSA IgG encapsulated immunoliposome;
C. detecting patulin by using a fluorescence method based on immunoliposomes;
D. specificity test of a patulin fluorescence detection method based on immunoliposomes;
and E, detecting patulin by an HPLC method.
The preparation of the fluorescent dye encapsulated liposome in the step A comprises the following steps:
and dissolving the DPPE and the SATA in a chloroform solution, and carrying out ultrasonic treatment to form DPPE-SATA. Dissolving DPPE-SATA, DPPC, DPPG and cholesterol in a mixed solution of chloroform and methanol, sonicating to form lipids, adding a sealant, sonicating. The organic solvent was removed by evaporation, leaving a deep purple gel-like suspension. The lipid suspension is added with the sealant and sonicated, followed by repeated vortexing, evaporation and sonication until the mixture becomes a homogeneous suspension. The suspension was extruded through a membrane filter to obtain liposomes of uniform size. Liposomes encapsulating SRB uniformly in size were dialyzed overnight against dialysis membrane in HEPES buffer.
The chloroform solution contained 0.7% triethylamine.
The sealant was SRB dispersed in 0.02M HEPES buffer, where the concentration of SRB was 100mM and the pH of the sealant was 7.5.
The HEPES buffer concentration of 0.01M, pH7.5, containing 0.2M NaCl and 0.01% NaN 3.
The step of preparing immunoliposome in the step B is as follows:
to prepare IgG-labeled liposomes, sulfo-KMUS was added to an anti-patulin-BSA IgG solution and the reaction was shaken to prepare derivatized IgG with maleimide groups. The derivatized anti-patulin-BSA IgG was dialyzed. Meanwhile, hydroxylamine hydrochloride was dissolved in HEPES solution and mixed with liposome solution to remove acetylthioacetic acid groups on the liposome nanoparticles. The thiol-containing liposome solution was adjusted to pH 7.0 and then mixed with derivatized IgG bearing maleimide groups. The mixture was incubated at room temperature for 4 hours after nitrogen purging, and then overnight at 4 ℃ in the dark. Ethylmaleimide was added to the reaction and gently shaken at room temperature to quench unreacted thiol groups. The mixture was then filtered and dialyzed against 0.02M TBS solution.
The concentration of sulfo-KMUS is 2mg/mL, and the sulfo-KMUS is dissolved in a mixed solvent of DMSO and methanol (2:1, v/v).
The dialysis conditions of the derivatized anti-patulin-BSA IgG are as follows: dialyzed overnight against light in HEPES solution at 0.02M, pH 7.0, containing 0.15M NaCl and 0.01% NaN 3.
The HEPES solution was 0.1M in concentration, pH7.5, and contained 25mM EDTA.
The ethyl maleimide concentration is 100mM, dissolved in 0.02M TBS solution, TBS solution pH 7.0.
The filtration conditions of the mixture are as follows: sepharose CL-4B column, equilibrated with 0.02M TBS.
In the step C, the step of detecting patulin by using a fluorescence method based on immunoliposomes comprises the following steps:
the prepared immunoliposome stock solution was diluted with TBS buffer for future use. First, anti-patulin-BSA IgG was dropped onto a 96-well microplate and incubated for 2 h. The 96-well plate was then washed with Phosphate Buffered Saline (PBST). And adding the diluted patulin solution into a washed 96-well microplate, and incubating for 1 h. The diluted immunoliposome solution was added to a 96-well microplate washed with PBST, and after incubation for 1h, the plate was washed three times with PBST. Finally, OG solution is added to a 96-well microplate to dissolve the immunoliposomes and release the fluorescent agent SRB. The fluorescence intensity signal is measured. Serial dilutions of patulin were analyzed to determine the limit of detection.
The TBS buffer solution has a concentration of 0.01M, contains 0.04M sucrose, and has a dilution ratio of 1:10 to the prepared immunoliposome stock solution.
The Phosphate Buffer (PBST) concentration is 0.01M, containing 0.05% Tween 20.
The incubation conditions were all 4 ℃.
The fluorescence detection conditions are as follows: the excitation wavelength is 550nm, and the emission wavelength is 585 nm; the instrument model was Infinite M200, Tecan, Mannedorf, Switzerland.
By adopting the technical scheme, the fluorescence intensity signal is measured under the conditions of the excitation wavelength of 550nm and the emission wavelength of 585nm, and the rapid detection of patulin can be realized.
The invention has the following beneficial effects:
compared with the existing HPLC or HPLC related methods, the fluorescence detection method based on the immunoliposome is very rapid, can detect the patulin in the apple juice sample within 3 hours, and realizes the rapid detection of the patulin. In addition, the fluorescence detection method based on the immunoliposome is simple and easy to implement, does not need complex pretreatment steps, does not need organic solvent extraction and washing processes, and is environment-friendly. The fluorescence detection method based on the immunoliposome is rapid, simple and convenient, and the detection limit is 3.15 mug/L.
Drawings
FIG. 1: a fluorescence detection standard curve of patulin, wherein the linear range is 0-150 mug/L; the standard curve equation is that Y is 4.3102X +55.432, R2=0.9641;
FIG. 2: fluorescence detection maps of patulin, bovine serum albumin and ochratoxin A based on immunoliposomes.
Detailed Description
The present invention is described in further detail below with reference to specific examples.
Example 1: preparation of fluorescent dye-encapsulated liposomes
DPPE, DPPC, DPPG, cholesterol and SRB are used as raw materials to prepare the fluorescent dye encapsulated liposome. Briefly, DPPE (7.2. mu. mol) and SATA (14.3. mu. mol) were dissolved in 1mL of 0.7% triethylamine in chloroform and sonicated for 1 minute under a nitrogen flush to form DPPE-SATA. DPPC (40.3. mu. mol), DPPG (4.2. mu. mol) and cholesterol (40.9. mu. mol) were dissolved in a mixed solution of 3mL of chloroform and 0.5mL of methanol, sonicated at 45 ℃ under a nitrogen purge for 1min to form lipids, and then immediately 2mL of a sealant (100mM SRB in 0.02M HEPES buffer; pH7.5) was added to the lipid mixture, sonicated at 45 ℃ under a nitrogen purge for 3 min. Thereafter, the organic solvent was removed by evaporation at 45 ℃ leaving a deep purple gel-like suspension. A further 2mL of sealant was added to the lipid suspension and sonication was performed for 1min, after which vortexing, evaporation and sonication were repeated until the mixture became a homogeneous suspension. Liposomes of uniform size were obtained by extruding the suspension through 0.8 μm and 0.4 μm membrane filters in sequence. The liposomes encapsulating SRB with uniform particle size were dialyzed overnight against a dialysis membrane in 0.01M HEPES buffer containing 0.2M NaCl and 0.01% NaN3(pH 7.5).
Example 2: preparation of anti-Aspergillus clavatus-BSA IgG encapsulated immunoliposome
To prepare IgG-labeled liposomes, sulfo-KMUS (2mg/mL) dissolved in a mixed solvent of DMSO: methanol (2:1, v/v) was added to 1mL of anti-patulin-BSA IgG solution and reacted at room temperature at 70rpm for 3h to prepare derivatized IgG carrying a maleimide group. The derivatized anti-patulin-BSA IgG was dialyzed overnight at 4 ℃ against light in a 0.02M HEPES solution containing 0.15M NaCl and 0.01% NaN3(pH 7.0) using a dialysis membrane. Meanwhile, 30. mu. L0.5M hydroxylamine hydrochloride was dissolved in 0.1M HEPES solution containing 25mM EDTA (pH7.5) and mixed with 300. mu.L of the liposome solution to remove the acetylthioacetic acid group on the liposome nanoparticles. After purging with nitrogen for 1min, the liposome solution was reacted at room temperature for 2 h. The thiol-containing liposome solution was adjusted to pH 7.0 with 0.5M HEPES solution and mixed with derivatized IgG bearing maleimide groups. The mixture was purged with nitrogen for 1min and incubated at room temperature for 4h, then overnight at 4 ℃ in the absence of light. Ethylmaleimide dissolved in 0.02M TBS (pH 7.0) at a concentration of 100mM was added to the reaction and unreacted thiol groups were quenched by gentle shaking (70rpm) at room temperature for 30 min. The mixture was then filtered on a Sepharose CL-4B column equilibrated in 0.02M TBS. The collected immunoliposome solution was dialyzed against a dialysis membrane in 0.02M TBS solution.
The characteristics of the liposomes and anti-A.clavuligerus-BSA IgG encapsulated immunoliposomes are shown in Table 1.
TABLE 1 characterization of liposomes and immunoliposomes
All experiments were repeated three times and the data represent the mean standard deviation.
As can be seen from the data in Table 1, the liposome particle size increased, indicating that immunoliposomes were successfully prepared by coating liposomes with anti-Aspergillus clavus-BSA IgG. Assuming an initial concentration of 100mM SRB, the internal volumes of both the liposomes and immunoliposomes developed were 3.03X 10-12. mu.L, with SRB encapsulated at a concentration of 3.03X 10-13. mu. mol. As shown in Table 1, the polydispersity indexes of the prepared liposome and immunoliposome are 0.19 + -0.00 and 0.17 + -0.01, respectively, and the low polydispersity index indicates that the prepared liposome and immunoliposome have good stability. The zeta potential of the nanoparticles reflects the potential stability of the colloidal system. When the particles in the suspension have a large negative or positive zeta potential, the particles will repel each other, stabilizing the suspension. As shown in table 1, both liposomes and immunoliposomes have a negative zeta potential, indicating that the particles in suspension have resistance to clumping together. The experimental result shows that the prepared liposome and the immunoliposome are stable and uniform.
Example 3: fluorescence method for detecting patulin based on immunoliposome
mu.L of anti-patulin-BSA IgG (1. mu.g/mL) was added dropwise to a 96-well microplate and incubated at 4 ℃ for 2 h. The 96-well plates were washed with 200. mu.L of 0.01M Phosphate Buffered Saline (PBST) containing 0.05% Tween 20. mu.L of the diluted patulin solution was added to the washed 96-well microplate and incubated at 4 ℃ for 1 h. mu.L of the diluted immunoliposome solution was added to a 96-well microplate washed with 200. mu.L of PBST. The immunoliposome was cultured in a 96-well microplate at 4 ℃ for 1 hour, and then the 96-well microplate was washed three times with 200. mu.L of PBST. Finally, 200 μ L of OG solution was added to a 96-well microplate to dissolve the immunoliposomes releasing the fluorescent agent SRB. The fluorescence intensity signal was measured at an excitation wavelength of 550nm and an emission wavelength of 585 nm.
As a result, as shown in FIG. 1, when the concentration of patulin was increased from 0. mu.g/L to 150. mu.g/L, the fluorescence intensity was sharply increased. The fluorescence intensity signal has good linear relation with the patulin concentration, R20.9641, this shows that the inventive immunoliposome-based patulin fluorescence detection method can give quantitative analysis results. However, when the concentration of patulin was higher than 150. mu.g/L, the fluorescence intensity did not increase any more, indicating that the established method can detect but does not give a quantitative analysis result for detecting patulin because there is no linearity when the concentration of patulin is higher than 150. mu.g/L.
Example 4: specificity of immunoliposome-based fluorescence detection
A solution of ochratoxin A dissolved in 0.01M PBS was diluted to concentrations of 10. mu.g/L, 50. mu.g/L and 100. mu.g/L. These various concentrations of ochratoxin a are measured by the inventive immunoliposome-based fluorescence detection method. Also, to confirm the cross-reactivity of BSA to the inventive detection method, different concentrations of BSA in apple juice were also determined by the inventive immunoliposome-based fluorescence detection method.
The specificity of the immunoliposome-based patulin fluorescence detection method was examined using ochratoxin a as a control toxin. As shown in FIG. 2, when the concentration of ochratoxin A was increased from 0. mu.g/L to 200. mu.g/L, there was no change in the fluorescence signal, indicating that the method did not cross-react with ochratoxin A. On the other hand, BSA was part of the immunogen and cross-reactivity of BSA with the inventive immunoliposome-based fluorescence detection method was examined. As shown in FIG. 2, the immunoliposome-based fluorescence assay of the present invention has cross-reactivity with BSA, which may limit the application of the developed method for detecting patulin when BSA is present in a food sample.
Example 5: determination of patulin by HPLC method
Apple juice samples artificially contaminated with 10. mu.g/L, 50. mu.g/L, 100. mu.g/L, 200. mu.g/L and 500. mu.g/L patulin were analyzed by HPLC. First, patulin was extracted from an artificially contaminated apple juice sample with ethyl acetate, and the ethyl acetate fraction was treated with 0.5% sodium carbonate and passed through anhydrous sodium sulfate using a buchner funnel. The filtrate was dried under vacuum and dissolved in acetic acid solution (pH 4.0) and then filtered with a 0.22 μm syringe filter for HPLC analysis in an Ultimate 3000(Thermo Scientific; Waltham, MA, USA) equipped with a UV detector. mu.L of the sample was injected onto a C18 column (5 μm pore size, 4.6mm inner diameter × 250mm length) (Waters; Milford, Mass., USA) and eluted using 5% acetonitrile (v/v) at a constant flow rate of 0.5 mL/min. Patulin is detected at 276nm and quantified by comparing the signal from the sample to that from a known concentration of patulin.
Table 2 comparison of the recovery of patulin from artificially contaminated apple juice by immunoliposome-based fluorescence detection and HPLC detection.
All experiments were repeated three times and the data represent the mean standard deviation.
As shown in Table 2, when the spiked concentrations of patulin were 10. mu.g/L, 50. mu.g/L, 100. mu.g/L, 200. mu.g/L and 500. mu.g/L, the concentrations of patulin were 6.19. + -. 0.31. mu.g/L, 35.63. + -. 0.62. mu.g/L, 74.38. + -. 6.88. mu.g/L, 151.88. + -. 3.12. mu.g/L and 481.88. + -. 1.31. mu.g/L, respectively, and the recoveries were 61.88. + -. 0.03%, 71.25. + -. 0.01%, 74.38. + -. 0.07%, 75.02% and 96.38. + -. 0.03%, respectively. In HPLC analysis of patulin, organic solvents during extraction will significantly affect recovery. Low recovery indicates loss of patulin during extraction. When the standard addition concentrations of patulin are 10 mug/L, 50 mug/L and 100 mug/L, the recovery rates of the immunoliposome-based fluorescence detection method are 73.24 +/-0.06%, 101.73 +/-1.55% and 98.74 +/-4.88%, respectively, which indicates that the method is sensitive and reliable for detecting patulin. When the spiked concentrations of patulin were 200. mu.g/L and 500. mu.g/L, the recovery rates were 69.97. + -. 0.17% and 32.7. + -. 1.31%, which is consistent with the method for detecting patulin in a pure solution, which has a good linear relationship in the range of patulin concentrations of 0. mu.g/L to 150. mu.g/L. However, the linearity of the process is reduced in both pure solutions and artificially contaminated apple juice solutions when the patulin concentration is higher than 200. mu.g/L.
Claims (10)
1. The immunoliposome coated with the fluorescent dye is characterized in that the immunoliposome is prepared by the following steps:
1) dissolving DPPE and SATA in a chloroform solution, and carrying out ultrasonic treatment to form DPPE-SATA; dissolving DPPE-SATA, DPPC, DPPG and cholesterol in a mixed solution of chloroform and methanol, and carrying out ultrasonic treatment to form liposome; the liposome is encapsulated by the fluorescent dye to obtain the fluorescent dye encapsulated liposome;
2) modifying the liposome encapsulated by the fluorescent dye by using the antibody derived from the sulfo-KMUS to obtain the immune liposome encapsulating the fluorescent dye.
2. The fluorescent dye-encapsulated immunoliposome of claim 1, wherein the chloroform solution in step 1) contains 0.7% triethylamine.
3. The immunoliposome encapsulating a fluorescent dye according to claim 1, wherein the fluorescent dye of step 1) is dispersed in 0.02M HEPES buffer at a concentration of 100mM and pH 7.5.
4. The fluorescent dye-encapsulated immunoliposome of claim 3, wherein said HEPES buffer has a concentration of 0.01M, a pH of 7.5, and comprises 0.2M NaCl and 0.01% NaN3。
5. The immunoliposome encapsulated with a fluorescent dye of claim 1, wherein the specific steps of step 2) are:
1) adding sulfo-KMUS into an anti-patulin-BSA IgG solution, carrying out a shaking reaction to prepare a derivatized IgG with a maleimide group, and dialyzing the derivatized anti-patulin-BSA IgG;
2) dissolving hydroxylamine hydrochloride in HEPES solution, and mixing with liposome solution to remove acetylthioacetic acid groups on the liposome nanoparticles;
3) adjusting the pH of the liposome solution containing sulfydryl to 7.0, and mixing with the derivatized IgG with maleimide groups;
4) the mixture is cultured for 4 hours at room temperature after being blown by nitrogen, and then cultured overnight at 4 ℃ in a dark condition;
5) adding ethylmaleimide to the reaction in step 4), gently shaking at room temperature to quench unreacted thiol, and then, filtering the mixture and dialyzing against 0.02M TBS solution to prepare immunoliposome encapsulating a fluorescent dye.
6. The fluorescent dye-encapsulated immunoliposome according to claim 5, wherein the concentration of sulfo-KMUS in step 1) is 2mg/mL, and is dissolved in a mixed solvent of DMSO and methanol (2:1, v/v), wherein DMSO: the volume ratio of the methanol is 2: 1; the conditions for dialysis of derivatized anti-patulin-BSA IgG were: dialyzing overnight in HEPES solution with light shielding, wherein the HEPES solution has a concentration of 0.02M and a pH of 7.0, and contains 0.15M NaCl and 0.01% NaN3。
7. The fluorescent dye-encapsulated immunoliposome of claim 5, wherein the HEPES solution in step 2) has a concentration of 0.1M, a pH of 7.5, and contains 25mM EDTA; in the step 3), the concentration of the ethylmaleimide is 100mM, and the ethylmaleimide is dissolved in a TBS solution of 0.02M, wherein the pH of the TBS solution is 7.0; step 5) the mixture was filtered on a Sepharose CL-4B column and equilibrated with 0.02M TBS.
8. Use of the fluorescent dye-encapsulated immunoliposome of claims 1-7 in the fluorescence detection of patulin.
9. The application of claim 8, wherein the application comprises the steps of:
1) diluting the prepared immunoliposome stock solution with TBS buffer solution for later use;
2) dripping anti-patulin-BSA IgG onto a 96-well microplate, incubating for 2 hours, and washing the 96-well microplate by using phosphate buffer solution PBST;
3) adding the diluted patulin solution into a washed 96-hole microporous plate, incubating for 1h, adding the diluted immunoliposome solution into the 96-hole microporous plate washed by PBST, incubating for 1h, and washing the microtiter plate for three times by PBST;
4) and adding the OG solution into a 96-well micro-porous plate to dissolve the immunoliposome to release the fluorescent agent SRB, and measuring a fluorescence intensity signal.
10. The use according to claim 9, wherein in step 1) the TBS buffer solution is 0.01M, contains 0.04M sucrose, and is diluted to the prepared immunoliposome stock solution in a ratio of 1: 10; in the step 2), the concentration of the phosphate buffer PBST is 0.01M, and the phosphate buffer PBST contains 0.05 percent of Tween 20; the incubation conditions are all 4 ℃, and the fluorescence detection conditions are as follows: the excitation wavelength was 550nm and the emission wavelength was 585 nm.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111361157.3A CN114088675A (en) | 2021-11-17 | 2021-11-17 | Immunoliposome wrapping fluorescent dye and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111361157.3A CN114088675A (en) | 2021-11-17 | 2021-11-17 | Immunoliposome wrapping fluorescent dye and application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114088675A true CN114088675A (en) | 2022-02-25 |
Family
ID=80301255
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111361157.3A Pending CN114088675A (en) | 2021-11-17 | 2021-11-17 | Immunoliposome wrapping fluorescent dye and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114088675A (en) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1987004795A1 (en) * | 1985-06-11 | 1987-08-13 | University Of Tennessee Research Corporation | Immunoliposome assay - methods and products |
WO2007083345A1 (en) * | 2006-01-23 | 2007-07-26 | D Auria Sabato | A competitive immunoassay for patulin detection |
CN101381773A (en) * | 2008-10-15 | 2009-03-11 | 山东出入境检验检疫局检验检疫技术中心 | Loop-mediated isothermal amplification fast detection method of producing potulin fungi |
CN101914189A (en) * | 2010-08-04 | 2010-12-15 | 上海交通大学 | Preparation method and application of molecular imprinted polymer on silica surface for specifically adsorbing patulin |
RU2012129389A (en) * | 2012-07-11 | 2014-01-20 | Федеральное государственное бюджетное учреждение "Федеральный центр охраны здоровья животных" (ФГБУ "ВНИИЗЖ") | METHOD FOR DETERMINING MYCOTOXINS IN ANIMAL AND VEGETABLE PRODUCTS |
CN105543375A (en) * | 2016-01-24 | 2016-05-04 | 湖南科技大学 | Detection method and detection kit for patulin |
KR20160064781A (en) * | 2014-11-28 | 2016-06-08 | 주식회사 디에이치랩 | Patulin-specific antibody and method for detecting patulin using the same |
US20170153235A1 (en) * | 2015-11-13 | 2017-06-01 | Gwangju Institute Of Science And Technology | Aptamer for specifically detecting patulin and patulin detection method using the same |
ES2849398A1 (en) * | 2020-02-17 | 2021-08-17 | Consejo Superior Investigacion | BIOCONJUGATES AND ANTIBODIES FOR THE DERIVATIZATION-ASSISTED IMMUNODETECTION OF PATULIN MYCOTOXIN (Machine-translation by Google Translate, not legally binding) |
-
2021
- 2021-11-17 CN CN202111361157.3A patent/CN114088675A/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1987004795A1 (en) * | 1985-06-11 | 1987-08-13 | University Of Tennessee Research Corporation | Immunoliposome assay - methods and products |
WO2007083345A1 (en) * | 2006-01-23 | 2007-07-26 | D Auria Sabato | A competitive immunoassay for patulin detection |
CN101381773A (en) * | 2008-10-15 | 2009-03-11 | 山东出入境检验检疫局检验检疫技术中心 | Loop-mediated isothermal amplification fast detection method of producing potulin fungi |
CN101914189A (en) * | 2010-08-04 | 2010-12-15 | 上海交通大学 | Preparation method and application of molecular imprinted polymer on silica surface for specifically adsorbing patulin |
RU2012129389A (en) * | 2012-07-11 | 2014-01-20 | Федеральное государственное бюджетное учреждение "Федеральный центр охраны здоровья животных" (ФГБУ "ВНИИЗЖ") | METHOD FOR DETERMINING MYCOTOXINS IN ANIMAL AND VEGETABLE PRODUCTS |
KR20160064781A (en) * | 2014-11-28 | 2016-06-08 | 주식회사 디에이치랩 | Patulin-specific antibody and method for detecting patulin using the same |
US20170153235A1 (en) * | 2015-11-13 | 2017-06-01 | Gwangju Institute Of Science And Technology | Aptamer for specifically detecting patulin and patulin detection method using the same |
CN105543375A (en) * | 2016-01-24 | 2016-05-04 | 湖南科技大学 | Detection method and detection kit for patulin |
ES2849398A1 (en) * | 2020-02-17 | 2021-08-17 | Consejo Superior Investigacion | BIOCONJUGATES AND ANTIBODIES FOR THE DERIVATIZATION-ASSISTED IMMUNODETECTION OF PATULIN MYCOTOXIN (Machine-translation by Google Translate, not legally binding) |
Non-Patent Citations (3)
Title |
---|
SHRUTI SHUKLA: "《Development of immunoliposome-based assay for the detection of Salmonella Typhimurium》", 《EUR FOOD RES TECHNOL》, vol. 234, 22 October 2011 (2011-10-22), pages 53 - 59 * |
XINJIE SONG: "《Development of Fluorescence-Based Liposome Immunoassay for Detection of Cronobacter muytjensii in Pure Culture》", 《CURR MICROBIOL》, vol. 70, 10 October 2014 (2014-10-10), pages 246 - 252 * |
XINJIE SONG: "《Immunoliposome-based fluorometric patulin assay by using immunomagnetic nanoparticles》", 《MICROCHIMICA ACTA》, vol. 186, no. 834, 22 November 2019 (2019-11-22), pages 1 - 7 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | Quantum-dot-based lateral flow immunoassay for detection of neonicotinoid residues in tea leaves | |
EP0965045B1 (en) | Method for isolating, in particular for detecting or quantifying an analyte in a medium | |
CN112067799B (en) | Immune magnetic adsorbent based on phenylboronic acid directional coupling antibody and preparation method thereof | |
Ji et al. | A highly sensitive immunoassay of pesticide and veterinary drug residues in food by tandem conjugation of bi-functional mesoporous silica nanospheres | |
FR2917174A1 (en) | MULTIPLE ANALYSIS OF BLOOD SAMPLES | |
US8932384B1 (en) | Surface enhanced raman spectroscopy gold nanorods substrates for detection of 2,4,6-trinitrotoulene and 3,5-dinitro-4-methylbenzoic acid explosives | |
CN108303415B (en) | Aptamer test strip for detecting aflatoxin B1, and preparation method and application thereof | |
CN105792925A (en) | Manufacture of magnetic particles | |
Lu et al. | Flow injection chemiluminescence immunoassay of microcystin-LR by using PEI-modified magnetic beads as capturer and HRP-functionalized silica nanoparticles as signal amplifier | |
Du et al. | Dual recognition and highly sensitive detection of Listeria monocytogenes in food by fluorescence enhancement effect based on Fe3O4@ ZIF-8-aptamer | |
Xu et al. | Flow injection chemiluminescent competitive immunoassay for the β-adrenergic agonist salbutamol using carboxylic resin beads and enzymatic amplification | |
US20200326338A1 (en) | Detection agent for bioassay and signal amplification method using same | |
Shestivska et al. | Evaluation of lipid peroxidation by the analysis of volatile aldehydes in the headspace of synthetic membranes using selected ion flow tube mass spectrometry | |
Dogan et al. | Multiplex enumeration of Escherichia coli and Salmonella enteritidis in a passive capillary microfluidic chip | |
Zhang et al. | Rapid determination of aflatoxin B1 by an automated immunomagnetic bead purification sample pretreatment method combined with high‐performance liquid chromatography | |
CN114088675A (en) | Immunoliposome wrapping fluorescent dye and application | |
EP3508849B1 (en) | Antibody measurement method using antigen-carrying insoluble carrier particles on which antigen is immobilized by different methods, and reagent for antibody measurement | |
Yu et al. | Development and application of a lateral flow colloidal gold immunoassay strip for the rapid quantification of ciprofloxacin in animal muscle | |
Wu et al. | Determination of aflatoxin M1 and chloramphenicol in milk based on background fluorescence quenching immunochromatographic assay | |
KR20210067916A (en) | Label-free Polydiacetylene Liposome-based Method for Detection of Exosomes | |
CN110720038B (en) | Means for preventing deterioration of immunoassay reagent containing insoluble carrier particles | |
Chauhan et al. | Analysis of amikacin in human serum by UHPLC with fluorescence detector using chloro-formate reagent with glycine | |
KR101573896B1 (en) | Biomarker protein and bacteria detection method based on pipette using magnetic nanoparticle and viscous solution | |
CN110095554B (en) | Method for analyzing milrinone related substances by high performance liquid chromatography | |
US9719989B2 (en) | Method for detecting food poisoning bacteria using magnetic nanoparticles and solution having high viscosity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |